(AVLV) American Century Trust - Overview
Etf: Large Cap, Value, Diversified, Equities
Dividends
| Dividend Yield | 1.44% |
| Yield on Cost 5y | 2.12% |
| Yield CAGR 5y | 0.13% |
| Payout Consistency | 97.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 12.5% |
| Relative Tail Risk | -1.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.91 |
| Alpha | 6.95 |
| Character TTM | |
|---|---|
| Beta | 0.916 |
| Beta Downside | 0.979 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.50% |
| CAGR/Max DD | 0.92 |
Description: AVLV American Century Trust January 07, 2026
The Avantis U.S. Large-Cap Value ETF (ticker AVLV) is a U.S.–based exchange-traded fund that targets large-cap equities classified as “value” stocks. The manager commits at least 80 % of assets to large-capitalization U.S. companies, using a multi-factor definition of “U.S. company” that includes headquarters location, principal operations, revenue sources, trading venue, legal domicile, and benchmark inclusion.
Key data points as of the most recent filing: the fund’s expense ratio is 0.10 %, placing it among the lower-cost large-value ETFs; its top five holdings are concentrated in financials, health care, and consumer staples, sectors that historically benefit from a rising interest-rate environment and slower earnings growth expectations. The ETF’s dividend yield hovers around 2.3 % and its price-to-book multiple averages 1.4×, indicating a tilt toward undervalued, cash-generating firms. Macro-driven factors such as the Federal Reserve’s policy stance and corporate earnings revisions are primary catalysts for the performance of U.S. value stocks.
For a deeper, data-driven look at AVLV’s valuation profile, consider reviewing the analytics available on ValueRay.
What is the price of AVLV shares?
Over the past week, the price has changed by +3.10%, over one month by +6.25%, over three months by +16.09% and over the past year by +21.51%.
Is AVLV a buy, sell or hold?
What are the forecasts/targets for the AVLV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 97.3 | 16.5% |
AVLV Fundamental Data Overview February 07, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 10.12b USD (10.12b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 10.12b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 10.12b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.29% (E(10.12b)/V(10.12b) * Re(9.29%) + (debt-free company))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)